INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

26,056 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$327K
3,900 sh
Jul 1, 2026
Page 288 of 652
← PrevNext →
Jul 2, 2026
traded Jul 1, 2026
+1d
SEC Form 4

Evidence

4
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$208K
12.8K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

0
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$35K
1,305 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

52
SX
Shen XiaojieDirector
PSNYPolestar Automotive Holding UK PLC
Open-market purchase
BUY$42K
2,436 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

47
VW
Vahland WinfriedDirector
PSNYPolestar Automotive Holding UK PLC
Open-market purchase
BUY$102K
6,000 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

47
BP
Bhalla Narinder PalChief Medical Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$99K
22.3K sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

45
TA
Tpg Gp A, Llc10% Owner
NANATPG Twin Brook Capital Income Fund
Open-market purchase
BUY$100.00M
3.97M sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

42
MP
Menell Richard PeterDirector
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$33K
15.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

39
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$116K
25.9K sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

39
LJ
Linz Terrence JamesPresident, Wholesale Brands
LZBLA-Z-BOY INC
Open-market sale
SELL$101K
2,500 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

39
CJ
Cicco Martin JDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$2,901
13 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

39
BF
Bettinger Davo Maria FernandaINVESTOR RELATIONS OFFICER
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$72K
21.2K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

39
CJ
Cicco Martin JDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$447
2 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

36
TE
Tamayo Louis EdwardChief Financial Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$21K
4,641 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

36
ZE
Zafrani EdenCHRO
NYAXNayax Ltd.
Open-market sale
SELL$32K
500 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
RP
Roe PeggyDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$18K
80 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
JP
Jones Nina PDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$447
2 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
RP
Roe PeggyDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$670
3 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
JP
Jones Nina PDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$9,149
41 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
RP
Roe PeggyDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$1,340
6 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

34
Donald S. Beyer, Jr.DJoint
VCVirginia Commlth 5.00% 09/15/29
Purchase
BUY$50K – $100KJun 18, 2026Jul 1, 2026
traded Jun 18, 2026
+13dHouse PTR

Evidence

32
BD
Berho Carranza Lorenzo DominiqueChief Executive Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$171K
50.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

32
BD
Berho Carranza Lorenzo DominiqueChief Executive Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$171K
50.0K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

32
BM
Berho Corona Lorenzo ManuelDirector
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$171K
50.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

32
BD
Berho Carranza DiegoChief Portfolio Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$12K
3,500 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

32
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$21K
4,666 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

31
David J. TaylorRSelf
CVXCHEVRON CORP
Purchase
BUY$1,001 – $15KJun 15, 2026Jul 1, 2026
traded Jun 15, 2026
+16dHouse PTR

Evidence

29
PJ
Panda Alex JosephEVP, Treasurer, Secretary, CFO
CMTCORE MOLDING TECHNOLOGIES INC
Open-market purchase
BUY$6,487
275 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

28
Max L. MillerRSelf
CCCliffwater Corporate Lending Fund (Ticker: CCLFX)
Partial sale
SELL$15K – $50KMay 29, 2026Jul 1, 2026
traded May 29, 2026
+33dHouse PTR

Evidence

28
Max L. MillerRSelf
CCCliffwater Corporate Lending Fund (Ticker: CCLFX)
Partial sale
SELL$15K – $50KMay 29, 2026Jul 1, 2026
traded May 29, 2026
+33dHouse PTR

Evidence

22
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Open-market sale · 10b5-1 plan
SELL$1.09M
36.3K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

21
BF
Barone FrancescaChief Scientific Officer
CADLCandel Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$236K
23.4K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

21
PD
Paul Josh D.Chief Accounting Officer
PANWPalo Alto Networks Inc
Open-market sale · 10b5-1 plan
SELL$311K
900 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

20
David J. TaylorRSelf
IBPInstalled Building Products, Inc.
Purchase
BUY$1,001 – $15KJun 15, 2026Jul 1, 2026
traded Jun 15, 2026
+16dHouse PTR

Evidence

20
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$552K
26.6K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

19
TR
ten Bosch John RoderickSVP of Laboratory Operations
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$170K
1,416 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

17
TS
Tyagarajan SeshuChief Technology Officer
CADLCandel Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$70K
7,000 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

15
CS
Carter Ryan StuartExecutive Vice President
GOODGLADSTONE COMMERCIAL CORP
Open-market purchase · 10b5-1 plan
BUY$1,226
100 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

14
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$210K
7,500 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

1
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$6,020
172 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence